Sonic (ASX:SHL) share price in the spotlight as it posts a 166% profit surge

The Sonic Healthcare Limited (ASX: SHL) could be poised to outperform the market today after it posted a more than doubling in net profit this morning.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Sonic Healthcare Limited (ASX: SHL) could be poised to outperform the market today after it posted a more than doubling in net profit this morning.

But the big increase in profit and revenue isn't the most exciting part of the result, although it will still be warmly welcomed by shareholders.

The medical diagnostic services group posted a 166% surge in first half net profit to $678 million. Earnings before interest, tax, depreciation and amortisation (EBITDA) jumped 89% to $1.3 billion as revenue improved by a third to $4.4 billion.

Sonic share price gets COVID profit booster shot

The Sonic share price has been a COVID-19 winner as demand for COVID tests have hit the roof in all the countries it operates in.

Sonic undertook more than 18 million PCR tests to date in around 60 Sonic laboratories located around the world.

Demand for such tests is likely to persist for a while yet. Even as mass vaccinations are rolled out globally, testing is key to controlling the spread.

Other tailwinds behind Sonic's share price  

But a bigger reason why I like its results is the operating leverage. Earnings have increased significantly ahead of revenue due to economies of scale.

Another exciting detail relates to its core business of testing and screening for non-COVID ailments. This part of the business took a big hit at the start of the pandemic due to social restrictions and patients fear of catching COVID at medical facilities.

"Our global base business revenue (excluding COVID testing) declined by 1% versus the comparative period, which was a very significant improvement versus the dramatic falls in base business we experienced from mid-March through May 2020," said Sonic's CEO, Dr Colin Goldschmidt.

"It appears our base business is becoming increasingly less affected by social restrictions and fear of infection, through better community understanding of the dangers in delaying or avoiding essential healthcare services."

New growth opportunities

Sonic upped its interim dividend by 6%, or 2 cents, to 36 cents a share and the group's gearing hit a record low. Sonic has $1.3 billion in liquidity before paying out the first half dividend.

That should still leave plenty in the tank to grow the business, and on that front, Sonic is striking an upbeat tone.

"Our management teams around the world are increasingly focussing on further growth opportunities, including acquisitions, contracts and joint ventures, supported by our very strong balance sheet," added Goldschmidt.

"We are currently bidding on significant opportunities in Australia, the UK, the USA and Alberta, Canada."

Motley Fool contributor Brendon Lau has no position in any of the stocks mentioned. Connect with me on Twitter @brenlau.

The Motley Fool Australia has recommended Sonic Healthcare Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

5 mini houses on a pile of coins.
Opinions

2 ASX shares I'd much rather buy than an investment property

Certain ASX shares can offer exposure to real estate with more income potential.

Read more »

A man holding a cup of coffee puts his thumb up and smiles with a laptop open.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

A man in a business suit rides a graphic image of an arrow that is rebounding on a graph.
Broker Notes

Down 43% this week, are Cochlear shares now the best bargain buy of the year?

A leading analyst believes the historic selloff in Cochlear shares could present a unique buying opportunity.

Read more »

A businessman wears armour and holds a shield and sword.
Share Market News

Nervous investors turn to ASX 200 defensives as global energy shock drags on

ASX investors sought safety in defensive sectors last week.

Read more »

A smiling woman at a hardware shop selects paint colours from a wall display.
Broker Notes

Wesfarmers shares: Buy, hold or sell?

A leading analyst delivers his verdict on Wesfarmers shares.

Read more »

An arrow crashes through the ground as a businessman watches on.
Share Fallers

After falling 43% in a week, are Cochlear shares now a buy?

Is this drop a warning sign?

Read more »

Businessman working and using Digital Tablet new business project finance investment at coffee cafe.
Broker Notes

Buy, hold, sell: Cochlear, CSL, and DroneShield shares

Are these hugely popular shares in the buy zone or not? Let's find out.

Read more »

Man holding out $50 and $100 notes in his hands, symbolising ex dividend.
Share Market News

How much do I need to invest in ASX shares to earn a $500 monthly passive income?

A $500 per month passive income is more achievable than you'd think.

Read more »